Temat: "Carcinoma, Hepatocellular" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Impact of acute decompensation on the prognosis of patients with hepatocellular carcinoma.
Autorzy:: Kondo T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Koroki K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kanzaki H; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kobayashi K; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.; Translational Research and Development Center, Chiba University Hospital, Chiba, Japan.
Kiyono S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nakamura M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kanogawa N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Saito T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ogasawara S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.; Translational Research and Development Center, Chiba University Hospital, Chiba, Japan.
Ooka Y; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Nakamoto S; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Chiba T; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Arai M; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.; Department of Medical Oncology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kato J; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kuboki S; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Ohtsuka M; Department of General Surgery, Graduate School of Medicine, Chiba University, Chiba, Japan.
Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2022 Jan 27; Vol. 17 (1), pp. e0261619. Date of Electronic Publication: 2022 Jan 27 (Print Publication: 2022).
Typ publikacji:: Journal Article
MeSH Terms:: Acute-On-Chronic Liver Failure/*epidemiology
Carcinoma, Hepatocellular/*surgery
Liver Cirrhosis/*epidemiology
Liver Neoplasms/*surgery
Aged ; Carcinoma, Hepatocellular/complications ; Carcinoma, Hepatocellular/pathology ; Decision Trees ; Female ; Humans ; Incidence ; Liver Neoplasms/complications ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Neoplasm Staging ; Prognosis ; Retrospective Studies ; Severity of Illness Index ; Survival Analysis ; Treatment Outcome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Regression of liver fibrosis and hepatocellular carcinoma development after HCV eradication with oral antiviral agents.
Autorzy:: Yoo HW; Department of Internal Medicine, SoonChunHyang University School of Medicine, Digestive Disease Center and Research Institute, SoonChunHyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon, 14584, Korea.
Park JY; Department of Internal Medicine, Yonsei University College of Medicine, Yonsei Liver Center, Severance Hospital, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, Korea. .
Kim SG; Department of Internal Medicine, SoonChunHyang University School of Medicine, Digestive Disease Center and Research Institute, SoonChunHyang University Bucheon Hospital, 170 Jomaru-ro, Wonmi-gu, Bucheon, 14584, Korea. .
Jung YK; Korea University Ansan Hospital, Ansan, Korea.
Lee SH; Soonchunhyang University College of Medicine Cheonan Hospital, Cheonan, Korea.
Kim MY; Wonju Severance Christian Hospital, Wonju, Korea.
Jun DW; Hanyang University Hospital, Seoul, Korea.
Jang JY; Soonchunhyang University College of Medicine Seoul Hospital, Seoul, Korea.
Lee JW; Inha University Hospital, Incheon, Korea.
Kwon OS; Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2022 Jan 07; Vol. 12 (1), pp. 193. Date of Electronic Publication: 2022 Jan 07.
Typ publikacji:: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiviral Agents/*administration & dosage
Carcinoma, Hepatocellular/*prevention & control
Hepatitis C, Chronic/*drug therapy
Liver Cirrhosis/*drug therapy
Liver Neoplasms/*prevention & control
Administration, Oral ; Aged ; Antiviral Agents/adverse effects ; Carbamates/administration & dosage ; Carcinoma, Hepatocellular/diagnosis ; Carcinoma, Hepatocellular/epidemiology ; Carcinoma, Hepatocellular/virology ; Drug Therapy, Combination ; Elasticity Imaging Techniques ; Female ; Hepatitis C, Chronic/diagnosis ; Hepatitis C, Chronic/epidemiology ; Hepatitis C, Chronic/virology ; Humans ; Imidazoles/administration & dosage ; Incidence ; Interferons/administration & dosage ; Isoquinolines/administration & dosage ; Liver Cirrhosis/diagnostic imaging ; Liver Cirrhosis/epidemiology ; Liver Cirrhosis/virology ; Liver Neoplasms/diagnosis ; Liver Neoplasms/epidemiology ; Liver Neoplasms/virology ; Male ; Middle Aged ; Prospective Studies ; Pyrrolidines/administration & dosage ; Retrospective Studies ; Ribavirin/administration & dosage ; Seoul ; Sulfonamides/administration & dosage ; Sustained Virologic Response ; Time Factors ; Treatment Outcome ; Valine/administration & dosage ; Valine/analogs & derivatives

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease.
Autorzy:: Ramai D; Division of Gastroenterology and Hepatology, University of Utah, Salt Lake City, UT 84132, USA.
Facciorusso A; Section of Gastroenterology, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.
Vigandt E; Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA.
Schaf B; Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA.
Saadedeen W; Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA.
Chauhan A; Department of Internal Medicine, The Brooklyn Hospital Center, Brooklyn, NY 11201, USA.
di Nunzio S; Polistudium s.r.l., 20135 Milano, Italy.
Shah A; Polistudium s.r.l., 20135 Milano, Italy.
Giacomelli L; Polistudium s.r.l., 20135 Milano, Italy.
Sacco R; Section of Gastroenterology, Department of Medical and Surgical Sciences, University of Foggia, 71122 Foggia, Italy.; Pokaż więcej
Źródło:: Cells [Cells] 2021 Dec 02; Vol. 10 (12). Date of Electronic Publication: 2021 Dec 02.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Carcinoma, Hepatocellular/*epidemiology
Liver/*metabolism
Liver Cirrhosis/*epidemiology
Non-alcoholic Fatty Liver Disease/*epidemiology
Animals ; Carcinoma, Hepatocellular/pathology ; Carcinoma, Hepatocellular/virology ; Disease Models, Animal ; Disease Progression ; Humans ; Inflammation/epidemiology ; Inflammation/pathology ; Inflammation/virology ; Lipid Peroxidation/physiology ; Liver/pathology ; Liver/virology ; Liver Cirrhosis/pathology ; Liver Cirrhosis/virology ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology ; Liver Neoplasms/virology ; Non-alcoholic Fatty Liver Disease/pathology ; Non-alcoholic Fatty Liver Disease/virology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients.
Autorzy:: Joshita S; Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. .; Department of Health Promotion Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. .
Ota M; Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.; Department of Health Promotion Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Kobayashi H; Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.; Department of Health Promotion Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Wakabayashi SI; Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Yamashita Y; Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Sugiura A; Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Yamazaki T; Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Tanaka E; Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.
Umemura T; Division of Gastroenterology and Hepatology, Department of Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.; Department of Health Promotion Medicine, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.; Consultation Center for Liver Diseases, Shinshu University Hospital, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.; Department of Life Innovation, Institute for Biomedical Sciences, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Nov 02; Vol. 11 (1), pp. 21424. Date of Electronic Publication: 2021 Nov 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular/*pathology
HLA-B Antigens/*genetics
Hepatitis B, Chronic/*complications
Liver Cirrhosis/*pathology
Liver Neoplasms/*pathology
Nucleosides/*therapeutic use
Receptors, KIR/*genetics
Receptors, KIR3DL1/*genetics
Aged ; Carcinoma, Hepatocellular/drug therapy ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/virology ; Female ; Follow-Up Studies ; Genotype ; Hepatitis B virus/isolation & purification ; Hepatitis B, Chronic/virology ; Humans ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/genetics ; Liver Cirrhosis/virology ; Liver Neoplasms/drug therapy ; Liver Neoplasms/genetics ; Liver Neoplasms/virology ; Male ; Middle Aged ; Prognosis ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic.
Autorzy:: Fründt T; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kuballa L; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Lütgehetman M; Institute of Microbiology and Virology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Nörz D; Institute of Microbiology and Virology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Arend H; Department of Internal Medicine, Israelitic Hospital, Hamburg, Germany.
Brehm TT; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Braunschweig, Germany.
Schulze Zur Wiesch J; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Horvatits T; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Center for Infection Research (DZIF), Partner Site Hamburg-Lübeck-Borstel-Riems, Braunschweig, Germany.
Horvatits K; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Huber S; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Wege H; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Department of Medicine, Hematology, Oncology, Gastroenterology and Infectious Diseases, Klinikum Esslingen, Esslingen, Germany.
Kluwe J; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Dec 23; Vol. 16 (12), pp. e0258450. Date of Electronic Publication: 2021 Dec 23 (Print Publication: 2021).
Typ publikacji:: Journal Article
MeSH Terms:: COVID-19/*epidemiology
Carcinoma, Hepatocellular/*virology
Liver Cirrhosis/*virology
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular/complications ; Cohort Studies ; Female ; Germany/epidemiology ; Humans ; Incidence ; Liver Cirrhosis/complications ; Liver Neoplasms/complications ; Liver Neoplasms/virology ; Male ; Middle Aged ; Pandemics ; Prospective Studies ; SARS-CoV-2/pathogenicity ; Tertiary Care Centers/trends

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma.
Autorzy:: Zenlander R; Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden. .; Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden. .; Department of Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden. .
Havervall S; Division of Gastroenterology, Department of Specialized Medicine, Danderyd Hospital, Stockholm, Sweden.; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.
Magnusson M; Division of Pediatrics, CLINTEC, Karolinska Institutet, Stockholm, Sweden.; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Engstrand J; Division of Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
Ågren A; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
Thålin C; Department of Clinical Sciences, Karolinska Institutet Danderyd Hospital, Stockholm, Sweden.; Department of Internal Medicine and Infectious Diseases, Danderyd Hospital, Stockholm, Sweden.
Stål P; Department of Medicine, Karolinska Institutet, Huddinge, Stockholm, Sweden.; Division of Hepatology, Department of Upper GI Diseases, Karolinska University Hospital, Stockholm, Sweden.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Sep 09; Vol. 11 (1), pp. 18025. Date of Electronic Publication: 2021 Sep 09.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular/*immunology
Liver/*immunology
Liver Cirrhosis/*immunology
Liver Neoplasms/*immunology
Neutrophils/*immunology
Thrombosis/*immunology
Aged ; Antithrombin III/immunology ; Biomarkers/blood ; Carcinoma, Hepatocellular/blood ; Carcinoma, Hepatocellular/diagnosis ; Carcinoma, Hepatocellular/pathology ; Case-Control Studies ; Citrullination ; DNA/blood ; Extracellular Traps/immunology ; Female ; Histones/blood ; Humans ; Inflammation ; Liver/metabolism ; Liver/pathology ; Liver Cirrhosis/blood ; Liver Cirrhosis/diagnosis ; Liver Cirrhosis/pathology ; Liver Neoplasms/blood ; Liver Neoplasms/diagnosis ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Neutrophils/pathology ; Peptide Hydrolases/blood ; Peptide Hydrolases/immunology ; Peroxidase/blood ; Thrombosis/blood ; Thrombosis/diagnosis ; Thrombosis/pathology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
Autorzy:: Waqar W; Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.
Asghar S; Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.
Manzoor S; Department of Healthcare Biotechnology, Atta-ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Sep 01; Vol. 16 (9), pp. e0256739. Date of Electronic Publication: 2021 Sep 01 (Print Publication: 2021).
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Biomarkers, Tumor/*analysis
Carcinoma, Hepatocellular/*diagnosis
Liver Cirrhosis/*diagnosis
Liver Neoplasms/*diagnosis
RNA, Messenger/*analysis
Adult ; Aged ; Biomarkers, Tumor/metabolism ; Blood Platelets/metabolism ; Carcinoma, Hepatocellular/blood ; Carcinoma, Hepatocellular/genetics ; Carcinoma, Hepatocellular/pathology ; Case-Control Studies ; Diagnosis, Differential ; Female ; Gene Expression Regulation, Neoplastic ; Healthy Volunteers ; Humans ; Liquid Biopsy/methods ; Liver/pathology ; Liver Cirrhosis/blood ; Liver Cirrhosis/genetics ; Liver Cirrhosis/pathology ; Liver Neoplasms/blood ; Liver Neoplasms/genetics ; Liver Neoplasms/pathology ; Male ; Middle Aged ; RNA, Messenger/metabolism ; Reproducibility of Results ; Trypsin Inhibitor, Kazal Pancreatic/genetics ; beta Catenin/genetics ; rhoA GTP-Binding Protein/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Role of ssDNA as a Noninvasive Indicator for the Diagnosis and Prognosis of Hepatocellular Carcinoma: An Exploratory Study.
Autorzy:: Zhao Q; Department of Clinical Laboratory, The Affiliated Wuxi People's Hospital of Nanjing Medical University, 299 Qingyang Road, Jiangsu Wuxi 214023, China.
Xu Y; Department of Clinical Laboratory, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, 68 Zhongshan Road, Jiangsu Wuxi 214002, China.
Yuan D; Department of Clinical Laboratory, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, 68 Zhongshan Road, Jiangsu Wuxi 214002, China.
Yang J; Department of Clinical Laboratory, The Affiliated Wuxi No. 2 People's Hospital of Nanjing Medical University, 68 Zhongshan Road, Jiangsu Wuxi 214002, China.
Wang Y; Department of Infection Management, Suzhou Hospital Affiliated Nanjing Medical University, 68 Guangji Road, Jiangsu Suzhou 215008, China.
Shen G; Department of Clinical Laboratory Medicine, Suzhou Ninth Hospital Affiliated to Soochow University, 2666 Ludang Road, Jiangsu Suzhou 215200, China.
Huang X; Research & Development, Jiangsu Yuan Biotechnology Co., Ltd, 333 Xingpu Road, Jiangsu Suzhou 215000, China.; Pokaż więcej
Źródło:: Disease markers [Dis Markers] 2021 Aug 04; Vol. 2021, pp. 9958909. Date of Electronic Publication: 2021 Aug 04 (Print Publication: 2021).
Typ publikacji:: Comparative Study; Journal Article
MeSH Terms:: Biomarkers, Tumor/*genetics
Carcinoma, Hepatocellular/*diagnosis
DNA, Single-Stranded/*genetics
Hepatitis, Chronic/*genetics
Liver Cirrhosis/*genetics
Liver Neoplasms/*diagnosis
Carcinoma, Hepatocellular/blood ; Carcinoma, Hepatocellular/genetics ; Case-Control Studies ; Early Detection of Cancer ; Female ; Hepatitis, Chronic/blood ; Humans ; Liver Cirrhosis/blood ; Liver Neoplasms/blood ; Liver Neoplasms/genetics ; Male ; Prognosis ; Prospective Studies ; ROC Curve ; Sensitivity and Specificity ; alpha-Fetoproteins/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Alpha-1 Antitrypsin and Hepatocellular Carcinoma in Liver Cirrhosis: SERPINA1 MZ or MS Genotype Carriage Decreases the Risk.
Autorzy:: Rabekova Z; Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.; First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic.
Frankova S; Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Jirsa M; Laboratory of Experimental Hepatology, Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.; Institute of Medical Biochemistry and Laboratory Diagnostics, First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic.
Neroldova M; First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic.; Laboratory of Experimental Hepatology, Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Lunova M; Laboratory of Experimental Hepatology, Experimental Medicine Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Fabian O; Clinical and Transplant Pathology Department, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Kveton M; Clinical and Transplant Pathology Department, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Varys D; Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.; First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic.
Chmelova K; Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.; First Faculty of Medicine, Charles University, 120 00 Prague, Czech Republic.
Adamkova V; Preventive Cardiology Centre, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Hubacek JA; Atherosclerosis Research Laboratory, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Spicak J; Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Merta D; Anaesthesiology and Resuscitation Department, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.
Sperl J; Department of Hepatogastroenterology, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic.; Department of Internal Medicine, 1st Faculty of Medicine, Charles University and Military University Hospital, 160 00 Prague, Czech Republic.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Sep 29; Vol. 22 (19). Date of Electronic Publication: 2021 Sep 29.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular/*genetics
Liver Cirrhosis/*genetics
Liver Neoplasms/*genetics
alpha 1-Antitrypsin/*genetics
Alleles ; Body Mass Index ; Carcinoma, Hepatocellular/complications ; Female ; Gene Frequency ; Genotype ; Humans ; Liver Cirrhosis/complications ; Liver Neoplasms/complications ; Male ; Middle Aged ; Multivariate Analysis ; Risk Factors ; Sex Factors ; alpha 1-Antitrypsin/blood

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Tumor size may influence the prognosis of solitary hepatocellular carcinoma patients with cirrhosis and without macrovascular invasion after hepatectomy.
Autorzy:: Liang BY; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie Fang Da Dao, Wuhan, 430030, China.
Gu J; Department of Hepatobiliary and Pancreatic Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Xiong M; Department of Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zhang EL; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie Fang Da Dao, Wuhan, 430030, China.
Zhang ZY; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie Fang Da Dao, Wuhan, 430030, China.
Chen XP; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie Fang Da Dao, Wuhan, 430030, China.
Huang ZY; Hepatic Surgery Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jie Fang Da Dao, Wuhan, 430030, China. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Aug 11; Vol. 11 (1), pp. 16343. Date of Electronic Publication: 2021 Aug 11.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular/*pathology
Liver Cirrhosis/*pathology
Liver Neoplasms/*pathology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Carcinoma, Hepatocellular/mortality ; Disease-Free Survival ; Female ; Hepatectomy/mortality ; Humans ; Liver Cirrhosis/mortality ; Liver Neoplasms/mortality ; Male ; Middle Aged ; Neoplasm Grading/methods ; Neoplasm Recurrence, Local/mortality ; Neoplasm Recurrence, Local/pathology ; Neoplastic Processes ; Prognosis ; Propensity Score ; Retrospective Studies ; Risk Factors ; Survival Rate ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Low serum magnesium concentration is associated with the presence of viable hepatocellular carcinoma tissue in cirrhotic patients.
Autorzy:: Parisse S; Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185, Rome, Italy.
Ferri F; Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185, Rome, Italy.
Persichetti M; Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185, Rome, Italy.
Mischitelli M; Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185, Rome, Italy.
Abbatecola A; Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185, Rome, Italy.
Di Martino M; Department of Radiological, Oncological and Anatomopathological Sciences, Sapienza University of Rome, Rome, Italy.
Lai Q; Hepato-Bilio-Pancreatic and Liver Transplant Unit, Department of Surgery, Sapienza University of Rome, Rome, Italy.
Carnevale S; Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185, Rome, Italy.
Lucatelli P; Department of Radiological, Oncological and Anatomopathological Sciences, Sapienza University of Rome, Rome, Italy.
Bezzi M; Department of Radiological, Oncological and Anatomopathological Sciences, Sapienza University of Rome, Rome, Italy.
Rossi M; Hepato-Bilio-Pancreatic and Liver Transplant Unit, Department of Surgery, Sapienza University of Rome, Rome, Italy.
De Santis A; Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185, Rome, Italy.
Spagnoli A; Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.
Ginanni Corradini S; Department of Translational and Precision Medicine, Sapienza University of Rome, Viale dell'Università 37, 00185, Rome, Italy. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Jul 26; Vol. 11 (1), pp. 15184. Date of Electronic Publication: 2021 Jul 26.
Typ publikacji:: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular/*blood
Carcinoma, Hepatocellular/*complications
Liver Cirrhosis/*blood
Liver Cirrhosis/*complications
Liver Neoplasms/*blood
Liver Neoplasms/*complications
Magnesium/*blood
Biomarkers, Tumor/blood ; Carcinoma, Hepatocellular/therapy ; Case-Control Studies ; Female ; Humans ; Liver Neoplasms/therapy ; Magnesium Deficiency/blood ; Magnesium Deficiency/etiology ; Male ; Middle Aged ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Somatic Mutations in Circulating Cell-Free DNA and Risk for Hepatocellular Carcinoma in Hispanics.
Autorzy:: Jiao J; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sanchez JI; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Thompson EJ; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Mao X; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
McCormick JB; Brownsville Regional Campus, School of Public Health, The University of Texas Health Science Center at Houston, Brownsville, TX 78520, USA.
Fisher-Hoch SP; Brownsville Regional Campus, School of Public Health, The University of Texas Health Science Center at Houston, Brownsville, TX 78520, USA.
Futreal PA; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Beretta L; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Jul 10; Vol. 22 (14). Date of Electronic Publication: 2021 Jul 10.
Typ publikacji:: Journal Article
MeSH Terms:: Mutation*
Biomarkers, Tumor/*genetics
Carcinoma, Hepatocellular/*pathology
Cell-Free Nucleic Acids/*genetics
Hispanic or Latino/*genetics
Liver Cirrhosis/*pathology
Liver Neoplasms/*pathology
Aged ; Biomarkers, Tumor/blood ; Carcinoma, Hepatocellular/blood ; Carcinoma, Hepatocellular/ethnology ; Carcinoma, Hepatocellular/genetics ; Cell-Free Nucleic Acids/blood ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Liver Cirrhosis/blood ; Liver Cirrhosis/ethnology ; Liver Cirrhosis/genetics ; Liver Neoplasms/blood ; Liver Neoplasms/ethnology ; Liver Neoplasms/genetics ; Male

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Identification of hepatic fibrosis inhibitors through morphometry analysis of a hepatic multicellular spheroids model.
Autorzy:: Song Y; Cancer Biology Laboratory, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, 13488, Gyeonggi-do, Republic of Korea.
Kim S; Cancer Biology Laboratory, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, 13488, Gyeonggi-do, Republic of Korea.
Heo J; Screening Discovery Platform, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, 13488, Gyeonggi-do, Republic of Korea.
Shum D; Screening Discovery Platform, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, 13488, Gyeonggi-do, Republic of Korea.
Lee SY; Cancer Biology Laboratory, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, 13488, Gyeonggi-do, Republic of Korea.
Lee M; Cancer Biology Laboratory, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, 13488, Gyeonggi-do, Republic of Korea.; Division of Bio-Medical Science and Technology, University of Science and Technology, Deajeon, 34113, Republic of Korea.
Kim AR; Cancer Biology Laboratory, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, 13488, Gyeonggi-do, Republic of Korea.
Seo HR; Cancer Biology Laboratory, Institut Pasteur Korea, 16, Daewangpangyo-ro 712 beon-gil, Bundang-gu, Seongnam-si, 13488, Gyeonggi-do, Republic of Korea. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 May 25; Vol. 11 (1), pp. 10931. Date of Electronic Publication: 2021 May 25.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular/*pathology
Colforsin/*pharmacology
Liver Cirrhosis/*pathology
Liver Neoplasms/*pathology
Sorafenib/*pharmacology
Tretinoin/*pharmacology
Carcinoma, Hepatocellular/drug therapy ; Carcinoma, Hepatocellular/metabolism ; Cell Line, Tumor ; Drug Synergism ; Epithelial-Mesenchymal Transition/drug effects ; Fibroblasts/cytology ; Hep G2 Cells ; Hepatic Stellate Cells/cytology ; Human Umbilical Vein Endothelial Cells ; Humans ; Liver Cirrhosis/drug therapy ; Liver Cirrhosis/metabolism ; Liver Neoplasms/drug therapy ; Liver Neoplasms/metabolism ; Small Molecule Libraries/pharmacology ; Spheroids, Cellular ; Tumor Microenvironment

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Familiarity Breeds Strategy: In Silico Untangling of the Molecular Complexity on Course of Autoimmune Liver Disease-to-Hepatocellular Carcinoma Transition Predicts Novel Transcriptional Signatures.
Autorzy:: Mukherjee S; Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, Kolkata 700026, India.
Kar A; Department of Signal Transduction and Biogenic Amines, Chittaranjan National Cancer Institute, Kolkata 700026, India.
Khatun N; Department of Signal Transduction and Biogenic Amines, Chittaranjan National Cancer Institute, Kolkata 700026, India.
Datta P; Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, Kolkata 700026, India.
Biswas A; Department of Signal Transduction and Biogenic Amines, Chittaranjan National Cancer Institute, Kolkata 700026, India.
Barik S; Department of In Vitro Carcinogenesis and Cellular Chemotherapy, Chittaranjan National Cancer Institute, Kolkata 700026, India.; Pokaż więcej
Źródło:: Cells [Cells] 2021 Jul 29; Vol. 10 (8). Date of Electronic Publication: 2021 Jul 29.
Typ publikacji:: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Computer Simulation*
Autoimmune Diseases/*complications
Carcinoma, Hepatocellular/*etiology
Liver Cirrhosis/*complications
Liver Neoplasms/*etiology
Autoimmune Diseases/genetics ; Biomarkers ; Carcinoma, Hepatocellular/genetics ; Carrier Proteins/analysis ; Carrier Proteins/genetics ; Cholangitis, Sclerosing/complications ; Cholangitis, Sclerosing/genetics ; Computational Biology ; Diacylglycerol O-Acyltransferase/analysis ; Diacylglycerol O-Acyltransferase/genetics ; Gene Expression Profiling ; Gene Expression Regulation ; Humans ; Liver Cirrhosis/genetics ; Liver Cirrhosis, Biliary/complications ; Liver Cirrhosis, Biliary/genetics ; Liver Diseases/complications ; Liver Diseases/genetics ; Liver Neoplasms/genetics ; Membrane Proteins/analysis ; Membrane Proteins/genetics ; Oligonucleotide Array Sequence Analysis ; Thyroid Hormones/analysis ; Thyroid Hormones/genetics ; Transaminases/analysis ; Transaminases/genetics ; Ubiquitin-Protein Ligase Complexes/analysis ; Ubiquitin-Protein Ligase Complexes/genetics ; Thyroid Hormone-Binding Proteins

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Autorzy:: Vieira Barbosa J; Division of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Division of Gastroenterology and Hepatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, United States of America.
Sahli R; Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Aubert V; Division of Immunology and Allergy, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Chaouch A; Division of Biostatistics, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Moradpour D; Division of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Fraga M; Division of Gastroenterology and Hepatology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2021 Apr 27; Vol. 16 (4), pp. e0250347. Date of Electronic Publication: 2021 Apr 27 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular/*epidemiology
Hepatitis B, Chronic/*epidemiology
Hepatitis D/*epidemiology
Liver Cirrhosis/*epidemiology
Liver Neoplasms/*epidemiology
Adult ; Black People ; Carcinoma, Hepatocellular/etiology ; Carcinoma, Hepatocellular/mortality ; Carcinoma, Hepatocellular/virology ; Coinfection ; Female ; Hepatitis B e Antigens/blood ; Hepatitis B virus/pathogenicity ; Hepatitis B, Chronic/complications ; Hepatitis B, Chronic/mortality ; Hepatitis B, Chronic/virology ; Hepatitis D/complications ; Hepatitis D/mortality ; Hepatitis D/virology ; Hepatitis Delta Virus/pathogenicity ; Human Migration/statistics & numerical data ; Humans ; Liver Cirrhosis/etiology ; Liver Cirrhosis/mortality ; Liver Cirrhosis/virology ; Liver Neoplasms/etiology ; Liver Neoplasms/mortality ; Liver Neoplasms/virology ; Liver Transplantation/statistics & numerical data ; Logistic Models ; Male ; Middle Aged ; Odds Ratio ; Prevalence ; RNA, Viral/blood ; Retrospective Studies ; Sex Factors ; Survival Analysis ; Switzerland/epidemiology ; White People

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Postprandial Glycogen Content Is Increased in the Hepatocytes of Human and Rat Cirrhotic Liver.
Autorzy:: Bezborodkina NN; Zoological Institute, Russian Academy of Sciences, Universitetskaya nab. 1, 199034 St. Petersburg, Russia.
Okovityi SV; Department of Pharmacology and Clinical Pharmacology, Saint Petersburg State Chemical Pharmaceutical University, 197022 St. Petersburg, Russia.
Kudryavtsev BN; Scientific-Clinical Centre, Pavlov First Saint Petersburg State Medical University, L'va Tolstogo str. 6-8, 197022 St. Petersburg, Russia.; Pokaż więcej
Źródło:: Cells [Cells] 2021 Apr 21; Vol. 10 (5). Date of Electronic Publication: 2021 Apr 21.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular*/etiology
Carcinoma, Hepatocellular*/metabolism
Hepatocytes*/metabolism
Hepatocytes*/pathology
Liver Cirrhosis*/complications
Liver Cirrhosis*/metabolism
Liver Neoplasms*/etiology
Liver Neoplasms*/metabolism
Glycogen/*metabolism
Animals ; Child ; Humans ; Male ; Rats

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression.
Autorzy:: Hoan NX; Department of Blood-Borne Infectious Diseases, Institute of Clinical Infectious Diseases, 108 Institute of Clinical Medical and Pharmaceutical Sciences, Hanoi, Vietnam. .; Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam. .; Institute for Tropical Medicine, University Hospital Tübingen, Tübingen, Germany. .
Huyen PTM; Department of Blood-Borne Infectious Diseases, Institute of Clinical Infectious Diseases, 108 Institute of Clinical Medical and Pharmaceutical Sciences, Hanoi, Vietnam.; Department of Biochemistry, 108 Institute of Clinical Medical and Pharmaceutical Sciences, Hanoi, Vietnam.
Binh MT; Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.; Faculty of Gastroenterology, 108 Institute of Clinical Medical and Pharmaceutical Sciences, Hanoi, Vietnam.
Trung NT; Centre for Genetic Consultation and Cancer Screening, 108 Institute of Clinical Medical and Pharmaceutical Sciences, Hanoi, Vietnam.
Giang DP; Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.
Linh BT; Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.
Dung DTN; Hanoi Medical University, Hanoi, Vietnam.
Pallerla SR; Institute for Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Kremsner PG; Institute for Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon.
Velavan TP; Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.; Institute for Tropical Medicine, University Hospital Tübingen, Tübingen, Germany.
Bang MH; Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.; Faculty of Gastroenterology, 108 Institute of Clinical Medical and Pharmaceutical Sciences, Hanoi, Vietnam.
Song LH; Department of Blood-Borne Infectious Diseases, Institute of Clinical Infectious Diseases, 108 Institute of Clinical Medical and Pharmaceutical Sciences, Hanoi, Vietnam.; Vietnamese-German Center for Medical Research (VG-CARE), Hanoi, Vietnam.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2021 Apr 08; Vol. 11 (1), pp. 7772. Date of Electronic Publication: 2021 Apr 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Carcinoma, Hepatocellular*/genetics
Carcinoma, Hepatocellular*/metabolism
Hepatitis B, Chronic*/genetics
Hepatitis B, Chronic*/metabolism
Liver Cirrhosis*/genetics
Liver Cirrhosis*/metabolism
Liver Neoplasms*/genetics
Liver Neoplasms*/metabolism
B7-H1 Antigen/*genetics
Programmed Cell Death 1 Receptor/*genetics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Disease Progression ; Female ; Genetic Predisposition to Disease ; Humans ; Male ; Middle Aged ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study.
Autorzy:: Wong WWL; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont. .
Haines A; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont.
Bremner KE; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont.
Yao Z; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont.
Calzavara A; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont.
Mitsakakis N; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont.
Kwong JC; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont.
Sander B; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont.
Thein HH; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont.
Krahn MD; School of Pharmacy (Wong), University of Waterloo, Kitchener, Ont.; Toronto Health Economics and Technology Assessment Collaborative (Wong, Haines, Bremner, Sander, Thein, Krahn), University Health Network; ICES Central (Wong, Yao, Calzavara, Kwong, Sander); Dalla Lana School of Public Health (Mitsakakis, Kwong, Sander, Thein) and Department of Family and Community Medicine (Kwong), University of Toronto; Public Health Ontario (Kwong, Sander), Toronto, Ont.; Pokaż więcej
Źródło:: CMAJ open [CMAJ Open] 2021 Mar 08; Vol. 9 (1), pp. E167-E174. Date of Electronic Publication: 2021 Mar 08 (Print Publication: 2021).
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Health Care Costs*
Carcinoma, Hepatocellular/*economics
Hepatitis C, Chronic/*economics
Liver Cirrhosis/*economics
Liver Neoplasms/*economics
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antiviral Agents/economics ; Antiviral Agents/therapeutic use ; Carcinoma, Hepatocellular/etiology ; Carcinoma, Hepatocellular/therapy ; Cohort Studies ; Female ; Hepatitis C, Chronic/complications ; Hepatitis C, Chronic/therapy ; Humans ; Liver Cirrhosis/etiology ; Liver Cirrhosis/therapy ; Liver Neoplasms/etiology ; Liver Neoplasms/therapy ; Liver Transplantation/economics ; Male ; Middle Aged ; Ontario ; Retrospective Studies ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Cooperative Role of Thrombopoietin and Vascular Endothelial Growth Factor-A in the Progression of Liver Cirrhosis to Hepatocellular Carcinoma.
Autorzy:: Vizio B; Department of Medical Sciences, University of Turin, Via Genova 3, 10126 Turin, Italy.
Bosco O; Department of Medical Sciences, University of Turin, Via Genova 3, 10126 Turin, Italy.
David E; Pathology Unit, AOU Città della Salute e della Scienza di Torino, University of Turin, Via Santena 7, 10126 Turin, Italy.
Caviglia GP; Department of Medical Sciences, University of Turin, Via Cavour 31, 10123 Turin, Italy.
Abate ML; Department of Medical Sciences, University of Turin, Via Cavour 31, 10123 Turin, Italy.
Schiavello M; Department of Medical Sciences, University of Turin, Via Genova 3, 10126 Turin, Italy.
Pucci A; Department of Histopathology, Pisa University Hospital, Via Roma 57, 56126 Pisa, Italy.
Smedile A; Department of Medical Sciences, University of Turin, Via Cavour 31, 10123 Turin, Italy.
Paraluppi G; General Surgery 2U and Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Corso Bramante 88, 10126 Turin, Italy.
Romagnoli R; General Surgery 2U and Liver Transplantation Center, AOU Città della Salute e della Scienza di Torino, University of Turin, Corso Bramante 88, 10126 Turin, Italy.
Lupia E; Department of Medical Sciences, University of Turin, Via Genova 3, 10126 Turin, Italy.
Bellone G; Department of Medical Sciences, University of Turin, Via Genova 3, 10126 Turin, Italy.
Montrucchio G; Department of Medical Sciences, University of Turin, Via Genova 3, 10126 Turin, Italy.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Feb 12; Vol. 22 (4). Date of Electronic Publication: 2021 Feb 12.
Typ publikacji:: Journal Article
MeSH Terms:: Carcinoma, Hepatocellular/*metabolism
Liver Cirrhosis/*metabolism
Liver Neoplasms/*metabolism
Neoplasm Proteins/*biosynthesis
Thrombopoietin/*biosynthesis
Vascular Endothelial Growth Factor A/*biosynthesis
Aged ; Autocrine Communication ; Carcinoma, Hepatocellular/etiology ; Carcinoma, Hepatocellular/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Hep G2 Cells ; Humans ; Liver Cirrhosis/complications ; Liver Cirrhosis/pathology ; Liver Neoplasms/etiology ; Liver Neoplasms/pathology ; Male ; Middle Aged ; Paracrine Communication

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: From Liver Cirrhosis to Cancer: The Role of Micro-RNAs in Hepatocarcinogenesis.
Autorzy:: Mohr R; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Özdirik B; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Lambrecht J; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Demir M; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Eschrich J; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Geisler L; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Hellberg T; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Loosen SH; Clinic for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty of Heinrich Heine University Düsseldorf, University Hospital Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.
Luedde T; Clinic for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty of Heinrich Heine University Düsseldorf, University Hospital Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.
Tacke F; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Hammerich L; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.
Roderburg C; Department of Hepatology and Gastroenterology, Campus Virchow Klinikum (CVK) and Campus Charité Mitte (CCM), Charité University Medicine Berlin, Augustenburger Platz 1, 13353 Berlin, Germany.; Clinic for Gastroenterology, Hepatology and Infectious Diseases, Medical Faculty of Heinrich Heine University Düsseldorf, University Hospital Düsseldorf, Moorenstraße 5, 40225 Düsseldorf, Germany.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2021 Feb 02; Vol. 22 (3). Date of Electronic Publication: 2021 Feb 02.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Carcinogenesis/*genetics
Carcinoma, Hepatocellular/*genetics
Liver Cirrhosis/*genetics
Liver Neoplasms/*genetics
MicroRNAs/*genetics
RNA, Neoplasm/*genetics
Animals ; Antineoplastic Agents/therapeutic use ; Carcinoma, Hepatocellular/etiology ; Carcinoma, Hepatocellular/therapy ; Cell Transformation, Neoplastic ; Clinical Trials as Topic ; Gene Expression Regulation, Neoplastic ; Hepatitis, Chronic/complications ; Hepatitis, Chronic/genetics ; Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Immunotherapy ; Liver Cirrhosis/complications ; Liver Neoplasms/etiology ; Liver Neoplasms/therapy ; Mice ; MicroRNAs/therapeutic use ; Neoplasm Proteins/antagonists & inhibitors ; Oligonucleotides/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Xenograft Model Antitumor Assays

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Carcinoma, Hepatocellular"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język